ROTE WILLIAM E. (Senior Vice President, R&D) sold 37.2% of their position (60K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.41M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001698262-25-000005
Officer· Senior Vice President, R&D
Since Nov 2018
-60K
Net shares
Net seller
$2.41M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+60K
Price / share
$20.61
Trade value
$1.24M
% of position
59.1%
12/24/2025
101.44K→161.44K
Common Stock
Direct
Shares
−60K
Price / share
$40.10
Trade value
$2.41M
% of position
37.2%
12/24/2025
161.44K→101.44K
Total
Net shares
+0.00
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/24/2025 | M · Option Exercise | +60K | $20.61 | $1.24M | 59.1% | 101.44K | 161.44K |
| Common Stock Direct | 12/24/2025 | S · Sale | −60K | $40.10 | $2.41M | 37.2% | 161.44K | 101.44K |
| Total | +0.00 | -$1.17M | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
60K shares
Shares
−60K
Strike price
20.61
Held after
0.00
Exercisable
—
12/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock60K shares | 12/24/2025 | M · Option Exercise | −60K | 20.61 | — | 0.00 |